Series Objectives

• Review the results of studies in myeloproliferative diseases, multiple myeloma, leukemia, lymphoma, and CAR-T cell therapy from ASCO 2026 and ASH 2025
• Discuss recent data on treatments for advanced head and neck cancers in the current practice
• Recite new information and advances regarding breast cancer treatment and patient outcomes research from the ASCO 2026 meeting and San Antonio Breast Conference 2025
• Review the current results of the recent trials in genitourinary cancer, sarcoma and melanoma as well early phase drugs in development presented at ASCO 2026.
• Identify opportunities to implement the latest advances in the management of gastrointestinal tract, hepatobiliary and pancreatic malignancies
• Narrate the outcome of recent clinical trials in non-small cell lung cancer, small-cell and other thoracic malignancies presented at ASCO 2026 and Targeted Therapy IASLC 2026 meetings